Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business Practice

Business & Regulation Trends & Forecasts

Redefining Pharma

| James Strachan

Should pharma companies transition from developing, manufacturing and pricing “drugs” to promoting “health”?

Business & Regulation Business Practice

GDUFA 2020

| Stephanie Sutton

GDUFA fees for 2020 have been decided – and include a significant drop in the fees for finished dosage facilities.

Manufacture Advanced Medicine

Advanced Medicines: Making it to Market

| Miguel Forte

When it comes to developing cell and gene therapies, you need to keep your eye on the end goal of commercial manufacturing.

Discovery & Development Clinical Trials

Giving Data the Gift of Meaning

| Gen Li, Jonathan Peachey

Clinical trials need an overhaul – and AI is the solution.

Discovery & Development Drug Discovery

The Sleeping Giant

| Stephanie Sutton

Will the antibiotic apocalypse kill us all?

Business & Regulation Trends & Forecasts

We Must Focus on Science, Not Geography

| Steve Arlington

In times of political and social upheaval, maintaining our links across borders and working closely together is more important than ever.

Business & Regulation Business Practice

Perpetual Preparedness

| James Strachan

With a no-deal Brexit still a real possibility, Merck continues to prepare for the worst case scenario.

Business & Regulation Business Practice

Expect the Unexpected

| Yong Guo

Scientific careers are inherently unpredictable, but there are a number of steps we can take to be prepared.

Business & Regulation Clinical Trials

Brexit Realities

| James Strachan

Our animation explores the unique challenges a "no-deal" Brexit poses for the drug development and advanced therapy sectors.

Business & Regulation Business Practice

Fourth Time’s a Charm

| James Strachan

We sit down with Nigel Theobald, Chief Executive, N4 Pharma. He tells us the story of his career and offers some advice for budding entrepreneurs.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Latest White Papers

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register